Successful treatment of the first adult case of ZMIZ1::ABL1-positive B cell lymphoblastic leukemia with dasatinib, chimeric antigen receptor T-cell therapy, and allogeneic hematopoietic stem cell transplantation

Cancer Genet. 2024 Jun:284-285:16-19. doi: 10.1016/j.cancergen.2024.03.005. Epub 2024 Mar 8.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Dasatinib* / therapeutic use
  • Female
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Immunotherapy, Adoptive
  • Male
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / genetics
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / therapy
  • Proto-Oncogene Proteins c-abl / genetics
  • Receptors, Chimeric Antigen / genetics
  • Transplantation, Homologous

Substances

  • Dasatinib
  • Receptors, Chimeric Antigen
  • Proto-Oncogene Proteins c-abl
  • ABL1 protein, human